A Randomized Controlled Trial of a Drug Use Review: Intervention for Sedative Hypnotic Medications

Medical Care

Volumn 36, Issue 7, 1998, Pages 1013-1021

  Smith, David H ^a   Christensen, Dale B ^a,c   Stergachis, Andy ^a   Holmes, Garth ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Medical Assistance Administration   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Drug utilization review; Medicaid; Prescribing; Sedative hypnotic

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; DRUG USE; EPIDEMIOLOGY; FEMALE; FRACTURE; HUMAN; MALE; MEDICAID; MEDICAL EDUCATION; METHODOLOGY; MIDDLE AGED; PRACTICE GUIDELINE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; STATISTICS; UNITED STATES; UTILIZATION REVIEW; WRITING;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; BIAS (EPIDEMIOLOGY); CLUSTER ANALYSIS; CORRESPONDENCE; DRUG UTILIZATION REVIEW; EDUCATION, MEDICAL, CONTINUING; FEMALE; FRACTURES, BONE; HUMANS; MALE; MEDICAID; MIDDLE AGED; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; REGRESSION ANALYSIS; UNITED STATES; WASHINGTON;

EID: 0032113276     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199807000-00008     Document Type: Article

References (22)

1. Soumerai SB, Lipton HL. Computer based drug-utilization review: Risk, benefit, or boondoggle? N Engl J Med 1995;332:1641.
2. Wickizer TM. The effect of utilization review on hospital use an expenditures: A review of the literature and an update on recent findings. Med Care Rev 1990;47:327.
3. Lipton HL, Byrns PJ, Soumerai SB, Chrischelles EA. Pharmacists as agents of change for rational drug therapy. Int J Tech Assess Health Care 1995;11:485.
4. Lipton HL, Bird JA. Drug utilization review in ambulatory settings: State of the science and directions for outcomes research. Med Care 1993:31;12.
5. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: A critical analysis of the controlled literature. Milbank Q 1989;67:2.
6. Rascati KL, Okano GJ, Burch C. Evaluation of physician intervention letters. Med Care 1996;34:760.
7. Zimmerman DR, Collins TM, Lipowski EE, Sainfort F. Evaluation of a DUR Intervention: A case study of histamine antagonists. Inquiry 1994;31:89.
8. Okano GJ, Rascati KL. Effects of Medicaid Drug Utilization Review intervention letters. Clin Ther 1995;17:525.
9. Collins TM, Mott DA, Bigelow WE, Zimmerman DR. A controlled letter intervention to change prescribing behavior: Results of a dual-targeted approach. Health Serv Res 1997;32:471.
10. Ray WA, Fink R, W, Federspiel CF. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987;316:363.
11. Neutel CI, Hirdes JP, Colleen JM, Patten SB. New evidence on benzodiazepine use and falls: The time factor. Age and Aging 1996;25:273.
12. Herings RMC, Stricker BHC, de Boer A, Bakker A, Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures. Arch Intern Med 1995;155:1801.
13. Gillin JC, Byerley WF. The diagnosis and management of insomnia. N Engl J Med 1990;322:239.
14. American Hospital Formulary Service. January 1995.
15. Kales A. Diagnosis and management of insomnia (Letter). N Engl J Med 1990;323:486.
16. Gillin JC. The long and the short of sleeping pills. N Engl J Med 1991;324:1734.
17. Ashton H. Guidelines for the rational use of benzodiazepines: When and what to use. Drugs 1994;18:25.
18. Nightingale SL. From the Food and Drug Administration. JAMA 1992;267:787.
19. SAS Institute Inc. SAS/STAT Users Guide: Basics. Cary, NC: SAS Institute Inc., 1983.
20. Drug Facts and Comparisons. 1994. St. Louis, MO: Facts and Comparisons, 1994.
21. Simpson JM, Klar N, Donner A. Accounting for cluster randomization: A review of primary prevention trials, 1990-1993. Am J Public Health 1995;85:1378.
22. SAS Institute Inc. SAS/STAT Software: Changes and Enhancements for Release 6.12, Cary, NC: SAS Institute Inc., 1996:21